Joanna Wdzieczak‐Bakala
Publications by Year
Research Areas
PI3K/AKT/mTOR signaling in cancer, Synthesis and biological activity, Chemical Synthesis and Analysis, Ubiquitin and proteasome pathways, Cancer therapeutics and mechanisms
Most-Cited Works
- → Isocombretastatins A versus Combretastatins A: The Forgotten isoCA-4 Isomer as a Highly Promising Cytotoxic and Antitubulin Agent(2009)265 cited
- → Inhibitor of hematopoietic pluripotent stem cell proliferation: purification and determination of its structure.(1989)243 cited
- → Discovery of Isoerianin Analogues as Promising Anticancer Agents(2011)142 cited
- → Reduction-Responsive Cholesterol-Based Block Copolymer Vesicles for Drug Delivery(2014)120 cited
- → Involvement of human plasma angiotensin I-converting enzyme in the degradation of the haemoregulatory peptide N-acetyl-seryl-aspartyl-lysyl-proline(1993)110 cited
- → Synthesis, Biological Evaluation of 1,1‐Diarylethylenes as a Novel Class of Antimitotic Agents(2009)89 cited
- → The tetrapeptide AcSDKP, an inhibitor of primitive hematopoietic cell proliferation, induces angiogenesis in vitro and in vivo(2003)82 cited
- → Conformationnally restricted naphthalene derivatives type isocombretastatin A-4 and isoerianin analogues: Synthesis, cytotoxicity and antitubulin activity(2012)75 cited
- → Study of gene expression alteration in male androgenetic alopecia: evidence of predominant molecular signalling pathways(2017)69 cited
- → New C5-Alkylated Indolobenzazepinones Acting as Inhibitors of Tubulin Polymerization: Cytotoxic and Antitumor Activities(2008)68 cited